DiaMedica Therapeutics Inc. (DMAC)
NASDAQ: DMAC · Real-Time Price · USD
6.22
-0.10 (-1.58%)
Apr 28, 2026, 4:00 PM EDT - Market closed

DiaMedica Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Net Income
-32.77-24.44-19.38-13.68-13.59
Upgrade
Depreciation & Amortization
0.040.040.030.030.02
Upgrade
Loss (Gain) From Sale of Investments
-0.94-1.34-1.22-0.010.16
Upgrade
Stock-Based Compensation
3.852.091.681.51.56
Upgrade
Other Operating Activities
0.080.080.070.060.06
Upgrade
Change in Accounts Receivable
-0.020.13-0.290.050.21
Upgrade
Change in Accounts Payable
0.540.010.190.23-0.59
Upgrade
Change in Other Net Operating Assets
0.161.370.190.31-0.08
Upgrade
Operating Cash Flow
-29.06-22.08-18.73-11.51-12.25
Upgrade
Capital Expenditures
-0.04-0.03-0.02-0.08-0.02
Upgrade
Sale of Property, Plant & Equipment
----0
Upgrade
Investment in Securities
-2.158.59-18.2811.62-20.52
Upgrade
Investing Cash Flow
-2.198.56-18.311.54-20.54
Upgrade
Long-Term Debt Repaid
-0.01-0.01-0.01-0.01-0.01
Upgrade
Net Debt Issued (Repaid)
-0.01-0.01-0.01-0.01-0.01
Upgrade
Issuance of Common Stock
44.291236.85-30.24
Upgrade
Other Financing Activities
-0.4----0.15
Upgrade
Financing Cash Flow
43.8811.9936.84-0.0130.09
Upgrade
Net Cash Flow
12.62-1.52-0.190.02-2.7
Upgrade
Free Cash Flow
-29.1-22.1-18.75-11.59-12.27
Upgrade
Free Cash Flow Per Share
-0.62-0.55-0.58-0.44-0.59
Upgrade
Cash Income Tax Paid
0.030.030.030.030.03
Upgrade
Levered Free Cash Flow
-18.19-11.68-11.45-6.69-7.37
Upgrade
Unlevered Free Cash Flow
-18.19-11.68-11.45-6.69-7.37
Upgrade
Change in Working Capital
0.681.510.090.59-0.46
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.